Solid oral administration preparation containing Candesartan cilexetil or Candesartan Hydrochlorothiazide and method for preparing solid oral administration preparation
The invention discloses a solid oral administration preparation containing Candesartan cilexetil or Candesartan Hydrochlorothiazide and a method for preparing the solid oral administration preparation. The solid oral administration preparation consists of the Candesartan cilexetil or the Candesartan...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WU QIAOMEI CHEN HAO YAN QIPING HU GONGYUN GAO HUIYAN PENG JUNQING |
| description | The invention discloses a solid oral administration preparation containing Candesartan cilexetil or Candesartan Hydrochlorothiazide and a method for preparing the solid oral administration preparation. The solid oral administration preparation consists of the Candesartan cilexetil or the Candesartan Hydrochlorothiazide and a pharmaceutic adjuvant, wherein the pharmaceutic adjuvant is a filling agent, a bonding agent, a disintegrant and the like. The invention provides a method for preparing the solid oral administration preparation. Pelletization is carried out by using a wet method; and solution containing ethanol is selected preferentially to carry out the pelletization. The solid oral administration preparation has excellent stability; and the provided preparation method is suitable for industrial production. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN101612151BB</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN101612151BB</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN101612151BB3</originalsourceid><addsrcrecordid>eNqNjjEOwjAMRbswIOAOFjsSAcEBWoE6scBeWY1LLaVxlHgATsQxCaILWyd__ff15HnxvopjCxLRAdqBPSeNqCweQqSAY27FK2bo71Cht5QwKuaaHT1I2WXBH6ifNkrbO4miPeOLLUHGMJD2YqHL85_-a0xTXlgWsw5dotV4F8X6fLpV9YaCNJQCtuRJm-pituZoduZgynI_afQBTt1a2w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Solid oral administration preparation containing Candesartan cilexetil or Candesartan Hydrochlorothiazide and method for preparing solid oral administration preparation</title><source>esp@cenet</source><creator>WU QIAOMEI ; CHEN HAO ; YAN QIPING ; HU GONGYUN ; GAO HUIYAN ; PENG JUNQING</creator><creatorcontrib>WU QIAOMEI ; CHEN HAO ; YAN QIPING ; HU GONGYUN ; GAO HUIYAN ; PENG JUNQING</creatorcontrib><description>The invention discloses a solid oral administration preparation containing Candesartan cilexetil or Candesartan Hydrochlorothiazide and a method for preparing the solid oral administration preparation. The solid oral administration preparation consists of the Candesartan cilexetil or the Candesartan Hydrochlorothiazide and a pharmaceutic adjuvant, wherein the pharmaceutic adjuvant is a filling agent, a bonding agent, a disintegrant and the like. The invention provides a method for preparing the solid oral administration preparation. Pelletization is carried out by using a wet method; and solution containing ethanol is selected preferentially to carry out the pelletization. The solid oral administration preparation has excellent stability; and the provided preparation method is suitable for industrial production.</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120912&DB=EPODOC&CC=CN&NR=101612151B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120912&DB=EPODOC&CC=CN&NR=101612151B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WU QIAOMEI</creatorcontrib><creatorcontrib>CHEN HAO</creatorcontrib><creatorcontrib>YAN QIPING</creatorcontrib><creatorcontrib>HU GONGYUN</creatorcontrib><creatorcontrib>GAO HUIYAN</creatorcontrib><creatorcontrib>PENG JUNQING</creatorcontrib><title>Solid oral administration preparation containing Candesartan cilexetil or Candesartan Hydrochlorothiazide and method for preparing solid oral administration preparation</title><description>The invention discloses a solid oral administration preparation containing Candesartan cilexetil or Candesartan Hydrochlorothiazide and a method for preparing the solid oral administration preparation. The solid oral administration preparation consists of the Candesartan cilexetil or the Candesartan Hydrochlorothiazide and a pharmaceutic adjuvant, wherein the pharmaceutic adjuvant is a filling agent, a bonding agent, a disintegrant and the like. The invention provides a method for preparing the solid oral administration preparation. Pelletization is carried out by using a wet method; and solution containing ethanol is selected preferentially to carry out the pelletization. The solid oral administration preparation has excellent stability; and the provided preparation method is suitable for industrial production.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjjEOwjAMRbswIOAOFjsSAcEBWoE6scBeWY1LLaVxlHgATsQxCaILWyd__ff15HnxvopjCxLRAdqBPSeNqCweQqSAY27FK2bo71Cht5QwKuaaHT1I2WXBH6ifNkrbO4miPeOLLUHGMJD2YqHL85_-a0xTXlgWsw5dotV4F8X6fLpV9YaCNJQCtuRJm-pituZoduZgynI_afQBTt1a2w</recordid><startdate>20120912</startdate><enddate>20120912</enddate><creator>WU QIAOMEI</creator><creator>CHEN HAO</creator><creator>YAN QIPING</creator><creator>HU GONGYUN</creator><creator>GAO HUIYAN</creator><creator>PENG JUNQING</creator><scope>EVB</scope></search><sort><creationdate>20120912</creationdate><title>Solid oral administration preparation containing Candesartan cilexetil or Candesartan Hydrochlorothiazide and method for preparing solid oral administration preparation</title><author>WU QIAOMEI ; CHEN HAO ; YAN QIPING ; HU GONGYUN ; GAO HUIYAN ; PENG JUNQING</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN101612151BB3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2012</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WU QIAOMEI</creatorcontrib><creatorcontrib>CHEN HAO</creatorcontrib><creatorcontrib>YAN QIPING</creatorcontrib><creatorcontrib>HU GONGYUN</creatorcontrib><creatorcontrib>GAO HUIYAN</creatorcontrib><creatorcontrib>PENG JUNQING</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WU QIAOMEI</au><au>CHEN HAO</au><au>YAN QIPING</au><au>HU GONGYUN</au><au>GAO HUIYAN</au><au>PENG JUNQING</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Solid oral administration preparation containing Candesartan cilexetil or Candesartan Hydrochlorothiazide and method for preparing solid oral administration preparation</title><date>2012-09-12</date><risdate>2012</risdate><abstract>The invention discloses a solid oral administration preparation containing Candesartan cilexetil or Candesartan Hydrochlorothiazide and a method for preparing the solid oral administration preparation. The solid oral administration preparation consists of the Candesartan cilexetil or the Candesartan Hydrochlorothiazide and a pharmaceutic adjuvant, wherein the pharmaceutic adjuvant is a filling agent, a bonding agent, a disintegrant and the like. The invention provides a method for preparing the solid oral administration preparation. Pelletization is carried out by using a wet method; and solution containing ethanol is selected preferentially to carry out the pelletization. The solid oral administration preparation has excellent stability; and the provided preparation method is suitable for industrial production.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN101612151BB |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Solid oral administration preparation containing Candesartan cilexetil or Candesartan Hydrochlorothiazide and method for preparing solid oral administration preparation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T05%3A45%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WU%20QIAOMEI&rft.date=2012-09-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN101612151BB%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |